Rakovina Therapeutics Inc. (TSXV:RKV)
Canada · Delayed Price · Currency is CAD 0.1450
-0.0050 (-3.33%)
At close: Feb 27, 2026
Rakovina Therapeutics Market Cap
Rakovina Therapeutics has a market cap or net worth of CAD 3.07 million as of March 2, 2026. Its market cap has decreased by -88.54% in one year.
Market Cap
3.07M
Enterprise Value
4.84M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since April 1, 2021, Rakovina Therapeutics's market cap has decreased from 14.88M to 3.07M, a decrease of -79.39%. That is a compound annual growth rate of -27.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 3.07M | 45.00% |
| Dec 31, 2025 | 2.11M | -92.08% |
| Dec 31, 2024 | 26.69M | 348.09% |
| Dec 29, 2023 | 5.96M | -52.61% |
| Dec 29, 2022 | 12.57M | -18.16% |
| Dec 31, 2021 | 15.36M | 3.25% |
| Apr 1, 2021 | 14.88M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cytophage Technologies | 6.43M |
| Restart Life Sciences | 5.93M |
| Aptose Biosciences | 5.51M |
| MYND Life Sciences | 5.22M |
| Quest PharmaTech | 5.07M |
| MindBio Therapeutics | 4.32M |
| XORTX Therapeutics | 3.41M |
| Gemina Laboratories | 3.06M |